The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders.

L. Leriche, E. Bezard, C. Gross, O. Guillin, B. Foll, J. Diaz, P. Sokoloff
CNSNDDT. 2006-02-01; 5(1): 25-43
DOI: 10.2174/187152706784111551


Lire sur PubMed

---